Old Web
English
Sign In
Acemap
>
authorDetail
>
J. Straub
J. Straub
Merck KGaA
Medicine
Internal medicine
Adverse effect
Clinical endpoint
Hepatocellular carcinoma
4
Papers
4
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Randomised Phase 1b/2 trial of tepotinib vs sorafenib in Asian patients with advanced hepatocellular carcinoma with MET overexpression.
2021
British Journal of Cancer
Baek-Yeol Ryoo
Ann-Li Cheng
Zhenggang Ren
Tae-You Kim
Hongming Pan
Kun-Ming Rau
Hye Jin Choi
Joong Won Park
Jee Hyun Kim
Chia-Jui Yen
Ho Yeong Lim
Dongli Zhou
J. Straub
Juergen Scheele
Karin Berghoff
Shukui Qin
Show All
Source
Cite
Save
Citations (2)
OFP01.01 Liquid Biopsy to Detect MET Alterations in Patients with Advanced NSCLC: Biomarker Analysis from the VISION Study
2021
Journal of Thoracic Oncology
Xiuning Le
Dariusz M. Kowalski
B.C. Cho
Pierfranco Conte
Eudald Felip
M. C. Garassino
Santiago Viteri
Gee-Chen Chang
John M. Richart
Luis Paz-Ares
Dilafruz Juraeva
J. Straub
Christopher Stroh
Paul K. Paik
Show All
Source
Cite
Save
Citations (0)
Phase 1b/2 trial of tepotinib in sorafenibpretreated advanced hepatocellular carcinoma with MET overexpression
2021
British Journal of Cancer
Thomas Decaens
Carlo Barone
Eric Assenat
Martin Wermke
Angelica Fasolo
Philippe Merle
Jean Frédéric Blanc
Véronique Grando
A. Iacobellis
Erica Villa
Joerg Trojan
J. Straub
R. Bruns
Karin Berghoff
Juergen Scheele
Eric Raymond
Sandrine Faivre
Show All
Source
Cite
Save
Citations (2)
OA06 Tepotinib in Non-Small Cell Lung Cancer with MET Exon 14-Skipping Mutations or MET Amplification: a Phase 2 Trial in Progress
2018
Journal of Thoracic Oncology
Paul K. Paik
Hiroshi Sakai
Rolf Bruns
Jürgen Scheele
J. Straub
E. Felip
Show All
Source
Cite
Save
Citations (0)
1